ESC Professional Premium Access

Predicting thrombus outcome during anticoagulation for left ventricular thrombus

Congress Presentation

About the speaker

Doctor Qing Yang

Fuwai Hospital Chinese Academy of Medical Sciences, Beijing (China)
0 follower

6 more presentations in this session

Baseline characteristics and outcomes of extended oral anticoagulant treatment in patients with venous thrombosis: a retrospective cohort study in France

Speaker: Mr R. Subash (Surrey, GB)

Thumbnail

Comparative effectiveness and safety of apixaban and low-molecular weight heparin among patients with venous thromboembolism and active cancer in an extended treatment setting

Speaker: Doctor A. Cohen (London, GB)

Thumbnail

The effect of DOAC-Stop on lupus anticoagulant testing in patients with pulmonary embolism receiving direct oral anticoagulants

Speaker: Professor A. Undas (Krakow, PL)

Thumbnail

Anticoagulant therapy beyond primary treatment among active cancer and non-cancer patients with venous thromboembolism in the United States

Speaker: Doctor A. Cohen (London, GB)

Thumbnail

Clinical characteristics and outcomes of super-low-dose edoxaban of 15 mg in patients with acute venous thromboembolism: insight from the COMMAND VTE Registry-2

Speaker: Doctor K. Kaneda (Kyoto, JP)

Thumbnail

Access the full session

Oral anticoagulation in patients with venous thromboembolism or left ventricular thrombus

Speakers: Doctor Q. Yang, Mr R. Subash, Doctor A. Cohen, Professor A. Undas, Doctor A. Cohen...
Thumbnail

About the event

Image

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

ESC 365 is supported by